Nirsevimab Benefits Beyond the First Year After Birth

Pediatrics · Published 2026-07-28 · DOI 10.1542/peds.2026-076580

Authors (3)

Cristina Tomatis-Souverbielle, Jason G. Newland, Natasha Halasa

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Tomatis-Souverbielle, C., Newland, J., Halasa, N. (2026). Nirsevimab Benefits Beyond the First Year After Birth. Pediatrics. https://doi.org/10.1542/peds.2026-076580

Related articles

• Nirsevimab and Hospitalization for Lower Respiratory Tract Infection During the Second Season · Pediatrics · 2026 · Cites or is cited by this article · Same journal
• Trends in Pediatric Hospitalizations Following Interfacility Transfer: 2009–2022 · Pediatrics · 2026 · Same journal
• Auricular Neurostimulation: A Novel Therapy for Abdominal Pain-Related Disorders of Gut-Brain Interaction · Pediatrics · 2026 · Same journal
• Telemedicine Use in Primary Care for Children: 2019–2024 · Pediatrics · 2026 · Same journal
• Hearing-Targeted Congenital Cytomegalovirus Screening: An 11-Year Experience · Pediatrics · 2026 · Same journal
• Building the Foundations for Trustworthy AI in Pediatrics · Pediatrics · 2026 · Same journal
• Blood Lead Testing Among Children Enrolled in Medicaid · Pediatrics · 2026 · Same journal
• Transplant Center Variability and Its Role in US Pediatric Liver Care Inequities · Pediatrics · 2026 · Same journal
• A Resource to Understand and Prevent Sudden Unexpected Infant Deaths · Pediatrics · 2026 · Same journal
• Child Welfare System Involvement in the United States: 2016–2023 · Pediatrics · 2026 · Same journal